Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
P. Pinto, C. Barbara, R. Dias, C. Canhao, J. Teixeira, M. J. Marques Gomes (Lisbon, Portugal). Exhaled nitric oxide in obstructive sleep apnea (OSA) patients: short and long term response to automatic positive airway pressure (APAP) therapy. Eur Respir J 2007; 30: Suppl. 51, 4102

Member's Comments

No comment yet.

Related content which might interest you: The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FENO) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Decreased plasma levels of nitric oxide (NO) derivatives in obstructive sleep apnea (OSA): response to automatic positive airway pressure (APAP) therapy Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 impact of continous positive airway pressure therapy on exhaled nitic oxide in obstructive sleep apnea syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003 Concentration of exhaled nitric oxide (FENO) in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004 Effect of nasal CPAP on exhaled nitric oxide in patients with obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 Oxydative stress in obstructive sleep apnea (OSA). Exhaled breath condensate (EBC) measurements (H2O2) in the follow-up of patients under CPAP. First results Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Oral nitric oxide in obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Nitric oxide in airways of patients with obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005 Exhaled nitric oxide is not altered in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II Year: 2007 Oxydative stress in obstructive sleep apnea: Value of fractional exhaled nitric oxide measurement Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005 Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Increased alveolar nitric oxide by trumpet model in patients with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Diurnal variation of exhaled nitric oxide in obstructive sleep apnea syndrome and healthy subjects Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Can fractional exhaled nitric oxide be useful to differentiate asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) from COPD-only Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010 Pulsed inhaled nitric oxide (iNO) improves exercise tolerance and shortness of breath (SOB) in severe COPD subjects with pulmonary hypertension (PH) Source: International Congress 2018 – Advances in exercise physiopathology Year: 2018 Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Obstructive sleep apnoea, inspiratory flows and exhaled nitric oxide Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006